Association of Plasma Levels of Fas Ligand with Severity and Outcome of Sepsis (VSports)
- PMID: 33577245
- DOI: 10.1097/SHK.0000000000001753
Association of Plasma Levels of Fas Ligand with Severity and Outcome of Sepsis
Abstract
Introduction: Levels of the apoptosis regulator Fas ligand (FasL) are associated with severity of sepsis, but its association with the mortality of sepsis and necroptosis, a regulated cell death mechanism, is not yet clear VSports手机版. We aimed to assess the association of FasL level with outcomes of sepsis and receptor interacting protein kinase-3 (RIPK3), an essential necroptosis mediator, for determining the relationship between FasL and necroptosis. .
Methods: Plasma FasL and RIPK3 levels were measured by ELISA from prospectively enrolled critically ill adult patients. The best cut-off level of FasL for 28-day mortality prediction was determined by Youden's index. The association between plasma levels of FasL and RIPK3 was assessed by a linear regression method V体育安卓版. .
Results: Among 188 patients, 58 (30. 9%) were diagnosed with sepsis and 84 (44. 7%) with septic shock, respectively. Plasma levels of FasL increased in the group order of control, sepsis, and septic shock groups (P for trend < 0. 001). For 142 patients with sepsis, organ dysfunction and septic shock were more prevalent in the group with plasma FasL levels that were higher than the best cut-off level. A significant difference in mortality between high and low FasL patients was observed up to 90 days (Log-rank P = 0. 013). FasL levels did not significantly change over day 3 and day 7 V体育ios版. FasL levels were not correlated with those of RIPK3. .
Conclusions: The plasma level of FasL was associated with severity of sepsis and was predictive of mortality. However, it was not correlated with RIPK3 level VSports最新版本. .
Copyright © 2021 by the Shock Society.
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority: a WHO resolution. N Engl J Med 377:414–417, 2017.
-
- Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K. International Forum of Acute Care T: assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193:259–272, 2016.
-
- Rello J, Valenzuela-Sanchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: a review of advances in management. Adv Ther 34:2393–2411, 2017.
-
- Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 45:486–552, 2017.
-
- Leligdowicz A, Matthay MA. Heterogeneity in sepsis: new biological evidence with clinical applications. Crit Care 23:80, 2019.
Publication types (VSports)
- "V体育ios版" Actions
- VSports在线直播 - Actions
V体育平台登录 - MeSH terms
- "VSports手机版" Actions
- "VSports注册入口" Actions
- "VSports注册入口" Actions
- Actions (V体育2025版)
- V体育安卓版 - Actions
- Actions (V体育安卓版)
- V体育官网入口 - Actions
- Actions (V体育平台登录)
- "V体育安卓版" Actions
Substances
- Actions (V体育平台登录)
- V体育平台登录 - Actions
LinkOut - more resources (V体育安卓版)
Full Text Sources
Other Literature Sources (VSports app下载)
Research Materials
Miscellaneous